Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Adriana Lombardi

Showing results (1-10 of 12) with videos related to

Pageof 2
Sort By:
Journal of Drugs in Dermatology : JDD|April 15, 2009
Telemedicine: current status in developed and developing countriesBabar Rao, Adriana Lombardi
Cutis|December 29, 2012
Adalimumab for the treatment of pityriasis rubra pilaris: a case reportCindy Wassef, Adriana Lombardi, Babar K Rao
Dermatitis : Contact, Atopic, Occupational, Drug|April 28, 2022
Atopic Dermatitis in Underrepresented Groups: An All of Us Database AnalysisIsabelle Moseley, Sara D Ragi, Adriana Lombardi
The Journal of Dermatological Treatment|April 18, 2022
Racial disparities in the management of skin ulcers: an analysis of the National Ambulatory Medical Care Survey, 2012-2018Isabelle H Moseley, Sara D Ragi, Adriana Lombardi
Journal of Drugs in Dermatology : JDD|July 11, 2013
Vitiligo surgical, laser, and alternative therapies: a review and case seriesCindy Wassef, Adriana Lombardi, Sairah Khokher, et al.
Human Reproduction (Oxford, England)|August 30, 2008
Src activation triggers capacitation and acrosome reaction but not motility in human spermatozoaGabriele Varano, Adriana Lombardi, Giulia Cantini, et al.
PPAR Research|August 2, 2008
Rosiglitazone inhibits adrenocortical cancer cell proliferation by interfering with the IGF-IR intracellular signalingGiulia Cantini, Adriana Lombardi, Elisabetta Piscitelli, et al.
European Journal of Cell Biology|June 12, 2010
Peroxisome-proliferator-activated receptor gamma (PPARgamma) is required for modulating endothelial inflammatory response through a nongenomic mechanismGiulia Cantini, Adriana Lombardi, Elisa Borgogni, et al.
Arteriosclerosis, Thrombosis, and Vascular Biology|February 2, 2008
A new mechanism involving ERK contributes to rosiglitazone inhibition of tumor necrosis factor-alpha and interferon-gamma inflammatory effects in human endothelial cellsAdriana Lombardi, Giulia Cantini, Elisabetta Piscitelli, et al.
Endocrine-Related Cancer|December 4, 2009
Rosiglitazone impairs proliferation of human adrenocortical cancer: preclinical study in a xenograft mouse modelMichaela Luconi, Monica Mangoni, Stefania Gelmini, et al.
Pageof 2

Showing results (1-10 of 12) with videos related to

Sort By:
Pageof 2
Journal of Drugs in Dermatology : JDD|April 15, 2009
Telemedicine: current status in developed and developing countriesBabar Rao, Adriana Lombardi
Cutis|December 29, 2012
Adalimumab for the treatment of pityriasis rubra pilaris: a case reportCindy Wassef, Adriana Lombardi, Babar K Rao
Dermatitis : Contact, Atopic, Occupational, Drug|April 28, 2022
Atopic Dermatitis in Underrepresented Groups: An All of Us Database AnalysisIsabelle Moseley, Sara D Ragi, Adriana Lombardi
The Journal of Dermatological Treatment|April 18, 2022
Racial disparities in the management of skin ulcers: an analysis of the National Ambulatory Medical Care Survey, 2012-2018Isabelle H Moseley, Sara D Ragi, Adriana Lombardi
Journal of Drugs in Dermatology : JDD|July 11, 2013
Vitiligo surgical, laser, and alternative therapies: a review and case seriesCindy Wassef, Adriana Lombardi, Sairah Khokher, et al.
Human Reproduction (Oxford, England)|August 30, 2008
Src activation triggers capacitation and acrosome reaction but not motility in human spermatozoaGabriele Varano, Adriana Lombardi, Giulia Cantini, et al.
PPAR Research|August 2, 2008
Rosiglitazone inhibits adrenocortical cancer cell proliferation by interfering with the IGF-IR intracellular signalingGiulia Cantini, Adriana Lombardi, Elisabetta Piscitelli, et al.
European Journal of Cell Biology|June 12, 2010
Peroxisome-proliferator-activated receptor gamma (PPARgamma) is required for modulating endothelial inflammatory response through a nongenomic mechanismGiulia Cantini, Adriana Lombardi, Elisa Borgogni, et al.
Arteriosclerosis, Thrombosis, and Vascular Biology|February 2, 2008
A new mechanism involving ERK contributes to rosiglitazone inhibition of tumor necrosis factor-alpha and interferon-gamma inflammatory effects in human endothelial cellsAdriana Lombardi, Giulia Cantini, Elisabetta Piscitelli, et al.
Endocrine-Related Cancer|December 4, 2009
Rosiglitazone impairs proliferation of human adrenocortical cancer: preclinical study in a xenograft mouse modelMichaela Luconi, Monica Mangoni, Stefania Gelmini, et al.
Pageof 2